Advertisement

Reduced Supraspinal Nociceptive Responses and Distinct Gene Expression Profile in CXBH Recombinant Inbred Mice

  • Shinya Kasai
    Affiliations
    Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
    Search for articles by this author
  • Kazutaka Ikeda
    Correspondence
    Address reprint requests to Kazutaka Ikeda, Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.
    Affiliations
    Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
    Search for articles by this author

      Abstract

      CXBH mice, known as an “opioid receptor-rich” strain, are a recombinant inbred mouse strain established by crossing the C57BL/6By and BALB/cBy strains. In the present study, we investigated nociceptive and antinociceptive sensitivity in CXBH mice and elucidated the underlying molecular mechanisms. CXBH mice exhibited slightly higher morphine-induced antinociception compared with C57BL/6J and BALB/cBy mice in the hot-plate test but not tail-flick test. CXBH mice exhibited a marked reduction of nociceptive sensitivity, regardless of the type of nociceptive stimulus, with the exception of tail stimulation. Changes in gene expression that corresponded to reduced nociceptive sensitivity in the brains of CXBH mice were observed in 62 transcripts, including pain- and analgesia-related transcripts, in a whole-genome expression assay. The total mRNA expression of opioid receptors was higher in CXBH mice than in C57BL/6J and BALB/cBy mice. However, the expression levels of MOR-1 mRNA, a major transcript of the μ opioid receptor gene, were not different among the C57BL/6J, BALB/cBy, and CXBH strains. In conclusion, supraspinal nociceptive responses were reduced in the CXBH mouse strain, and the expression levels of transcripts were altered in the brain of this strain.

      Perspective

      This article presents the nociceptive and antinociceptive properties of CXBH recombinant inbred mice and gene expression differences that may underlie nociceptive tolerance in the strain. The CXBH mouse strain may be a useful animal model to investigate the molecular basis of individual differences in supraspinal pain sensitivity.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baran A.
        • Shuster L.
        • Eleftheriou B.E.
        • Bailey D.W.
        Opiate receptors in mice: Genetic differences.
        Life Sci. 1975; 17: 633-640
        • Bzdega T.
        • Chin H.
        • Kim H.
        • Jung H.H.
        • Kozak C.A.
        • Klee W.A.
        Regional expression and chromosomal localization of the δ opiate receptor gene.
        Proc Natl Acad Sci U S A. 1993; 90: 9305-9309
        • Collier H.O.
        • Dinneen L.C.
        • Johnson C.A.
        • Schneider C.
        The abdominal constriction response and its suppression by analgesic drugs in the mouse.
        Br J Pharmacol Chemother. 1968; 32: 295-310
        • D'Amour F.
        • Smith D.
        A method for determining loss of pain sensation.
        J Pharmacol Exp Ther. 1941; 72: 74-79
        • Elmer G.I.
        • Pieper J.O.
        • Negus S.S.
        • Woods J.H.
        Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests.
        Pain. 1998; 75: 129-140
        • Foulkes T.
        • Wood J.N.
        Pain genes.
        PLoS Genet. 2008; 4: e1000086
        • Han W.
        • Kasai S.
        • Hata H.
        • Takahashi T.
        • Takamatsu Y.
        • Yamamoto H.
        • Uhl G.R.
        • Sora I.
        • Ikeda K.
        Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: A new genetic mechanism underlying differences in opioid sensitivity.
        Pharmacogenet Genomics. 2006; 16: 451-460
        • Hu X.
        • Bi J.
        • Loh H.H.
        • Wei L.N.
        Regulation of mouse κ opioid receptor gene expression by different 3'-untranslated regions and the effect of retinoic acid.
        Mol Pharmacol. 2002; 62: 881-887
        • Ikeda K.
        • Ichikawa T.
        • Kobayashi T.
        • Kumanishi T.
        • Oike S.
        • Yano R.
        Unique behavioural phenotypes of recombinant-inbred CXBK mice: Partial deficiency of sensitivity to μ- and κ-agonists.
        Neurosci Res. 1999; 34: 149-155
        • Ikeda K.
        • Kobayashi T.
        • Ichikawa T.
        • Kumanishi T.
        • Niki H.
        • Yano R.
        The untranslated region of μ-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.
        J Neurosci. 2001; 21: 1334-1339
        • Ikeda K.
        • Ide S.
        • Han W.
        • Hayashida M.
        • Uhl G.R.
        • Sora I.
        How individual sensitivity to opiates can be predicted by gene analyses.
        Trends Pharmacol Sci. 2005; 26: 311-317
        • Kasai S.
        • Han W.
        • Ide S.
        • Hata H.
        • Takamatsu Y.
        • Yamamoto H.
        • Uhl G.R.
        • Sora I.
        • Ikeda K.
        Involvement of the 3' non-coding region of the mu opioid receptor gene in morphine-induced analgesia.
        Psychiatry Clin Neurosci. 2006; 60: S11-S17
        • Kasai S.
        • Ikeda K.
        Pharmacogenomics of the human μ-opioid receptor.
        Pharmacogenomics. 2011; 12: 1305-1320
        • Kaufman D.L.
        • Keith Jr., D.E.
        • Anton B.
        • Tian J.
        • Magendzo K.
        • Newman D.
        • Tran T.H.
        • Lee D.S.
        • Wen C.
        • Xia Y.R.
        • Lusis A.J.
        • Evans C.J.
        Characterization of the murine μ opioid receptor gene.
        J Biol Chem. 1995; 270: 15877-15883
        • Kest B.
        • Hopkins E.
        • Palmese C.A.
        • Adler M.
        • Mogil J.S.
        Genetic variation in morphine analgesic tolerance: A survey of 11 inbred mouse strains.
        Pharmacol Biochem Behav. 2002; 73: 821-828
        • Kest B.
        • Palmese C.A.
        • Hopkins E.
        • Adler M.
        • Juni A.
        • Mogil J.S.
        Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: Evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
        Neuroscience. 2002; 115: 463-469
        • Kieffer B.L.
        • Gavériaux-Ruff C.
        Exploring the opioid system by gene knockout.
        Prog Neurobiol. 2002; 66: 285-306
        • Kim H.
        • Clark D.
        • Dionne R.A.
        Genetic contributions to clinical pain and analgesia: Avoiding pitfalls in genetic research.
        J Pain. 2009; 10: 663-693
        • Lacroix-Fralish M.L.
        • Mogil J.S.
        Progress in genetic studies of pain and analgesia.
        Annu Rev Pharmacol Toxicol. 2009; 49: 97-121
        • Lariviere W.R.
        • Wilson S.G.
        • Laughlin T.M.
        • Kokayeff A.
        • West E.E.
        • Adhikari S.M.
        • Wan Y.
        • Mogil J.S.
        Heritability of nociception: III. Genetic relationships among commonly used assays of nociception and hypersensitivity.
        Pain. 2002; 97: 75-86
        • Marek P.
        • Yirmiya R.
        • Liebeskind J.C.
        Strain differences in the magnitude of swimming-induced analgesia in mice correlate with brain opiate receptor concentration.
        Brain Res. 1988; 447: 188-190
        • Marek P.
        • Yirmiya R.
        • Liebeskind J.C.
        Genetic influences on brain stimulation-produced analgesia in mice: II. Correlation with brain opiate receptor concentration.
        Brain Res. 1990; 507: 155-157
        • Marek P.
        • Page G.G.
        • Ben-Eliyahu S.
        • Liebeskind J.C.
        N-methyl-D-aspartic acid (NMDA) receptor antagonist MK-801 blocks non-opioid stress-induced analgesia: I. Comparison of opiate receptor-deficient and opiate receptor-rich strains of mice.
        Brain Res. 1991; 551: 293-296
        • Mogil J.S.
        • Kest B.
        • Sadowski B.
        • Belknap J.K.
        Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: Influence of nociceptive assay.
        J Pharmacol Exp Ther. 1996; 276: 532-544
        • Mogil J.S.
        • Wilson S.G.
        • Bon K.
        • Lee S.E.
        • Chung K.
        • Raber P.
        • Pieper J.O.
        • Hain H.S.
        • Belknap J.K.
        • Hubert L.
        • Elmer G.I.
        • Chung J.M.
        • Devor M.
        Heritability of nociception: I. Responses of 11 inbred mouse strains on 12 measures of nociception.
        Pain. 1999; 80: 67-82
        • Mogil J.S.
        • Wilson S.G.
        • Bon K.
        • Lee S.E.
        • Chung K.
        • Raber P.
        • Pieper J.O.
        • Hain H.S.
        • Belknap J.K.
        • Hubert L.
        • Elmer G.I.
        • Chung J.M.
        • Devor M.
        Heritability of nociception: II. 'Types' of nociception revealed by genetic correlation analysis.
        Pain. 1999; 80: 83-93
        • Mogil J.S.
        The genetic mediation of individual differences in sensitivity to pain and its inhibition.
        Proc Natl Acad Sci U S A. 1999; 96: 7744-7751
        • Mogil J.S.
        • Bax M.B.
        The genetics of pain.
        in: Koltzenburg M. McMahon S. Wall and Melzack's Textbook of Pain. 5th edition. Elsevier, Philadelphia, PA2006: 159-174
        • Muraki T.
        • Oike N.
        • Shibata Y.
        • Nomoto T.
        Analgesic effect of μ- and κ-opioid agonists in beige and CXBK mice.
        J Pharm Pharmacol. 1991; 43: 210-212
        • Nielsen C.S.
        • Staud R.
        • Price D.D.
        Individual differences in pain sensitivity: Measurement, causation, and consequences.
        J Pain. 2009; 10: 231-237
        • Ono M.
        • Cole M.D.
        • White A.T.
        • Huang R.C.
        Sequence organization of cloned intracisternal A particle genes.
        Cell. 1980; 21: 465-473
        • Orsini C.
        • Bonito-Oliva A.
        • Conversi D.
        • Cabib S.
        Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains.
        Psychopharmacology. 2005; 181: 327-336
        • Pan Y.X.
        • Xu J.
        • Mahurter L.
        • Bolan E.
        • Xu M.
        • Pasternak G.W.
        Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene.
        Proc Natl Acad Sci U S A. 2001; 98: 14084-14089
        • Quock R.M.
        • Mueller J.L.
        • Vaughn L.K.
        Strain-dependent differences in responsiveness of mice to nitrous oxide (N2O) antinociception.
        Brain Res. 1993; 614: 52-56
        • Ramabadran K.
        Strain differences in the hyperalgesic effect of a novel κ receptor agonist, U-50488H in mice.
        Eur J Pharmacol. 1984; 98: 425-427
        • Ramabadran K.
        Stereoselective enhancement of nociception by opioids in different strains of mice.
        Jpn J Pharmacol. 1985; 37: 296-299
        • Randall L.O.
        • Selitto J.J.
        A method for measurement of analgesic activity on inflamed tissue.
        Arch Int Pharmacodyn Ther. 1957; 111: 409-419
        • Shigeta Y.
        • Kasai S.
        • Han W.
        • Hata H.
        • Nishi A.
        • Takamatsu Y.
        • Hagino Y.
        • Yamamoto H.
        • Koide T.
        • Shiroishi T.
        • Kasai K.
        • Tsunashima K.
        • Kato N.
        • Ikeda K.
        Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the μ opioid receptor gene in 10 inbred mouse strains.
        Pharmacogenet Genomics. 2008; 18: 927-936
        • Shuster L.
        • Webster G.W.
        • Yu G.
        • Eleftheriou B.E.
        A genetic analysis of the response to morphine in mice: Analgesia and running.
        Psychopharmacologia. 1975; 42: 249-254
        • Wilson S.G.
        • Bryant C.D.
        • Lariviere W.R.
        • Olsen M.S.
        • Giles B.E.
        • Chesler E.J.
        • Mogil J.S.
        The heritability of antinociception: II. Pharmacogenetic mediation of three over-the-counter analgesics in mice.
        J Pharmacol Exp Ther. 2003; 305: 755-764
        • Wilson S.G.
        • Smith S.B.
        • Chesler E.J.
        • Melton K.A.
        • Haas J.J.
        • Mitton B.
        • Strasburg K.
        • Hubert L.
        • Rodriguez-Zas S.L.
        • Mogil J.S.
        The heritability of antinociception: Common pharmacogenetic mediation of five neurochemically distinct analgesics.
        J Pharmacol Exp Ther. 2003; 304: 547-559
        • Woolfe G.
        • MacDonald A.
        The evaluation of the analgesic action of pethidine hydrochloride (Demerol).
        J Pharmacol Exp Ther. 1944; 80: 300-307
        • Yirmiya R.
        • Taylor A.N.
        Genetic differences in opiate receptor concentration and sensitivity to ethanol's effects.
        Pharmacol Biochem Behav. 1989; 33: 793-796